139 related articles for article (PubMed ID: 15196942)
1. Chemically sulfated Escherichia coli K5 polysaccharide derivatives as extracellular HIV-1 Tat protein antagonists.
Urbinati C; Bugatti A; Oreste P; Zoppetti G; Waltenberger J; Mitola S; Ribatti D; Presta M; Rusnati M
FEBS Lett; 2004 Jun; 568(1-3):171-7. PubMed ID: 15196942
[TBL] [Abstract][Full Text] [Related]
2. Antiangiogenic activity of semisynthetic biotechnological heparins: low-molecular-weight-sulfated Escherichia coli K5 polysaccharide derivatives as fibroblast growth factor antagonists.
Presta M; Oreste P; Zoppetti G; Belleri M; Tanghetti E; Leali D; Urbinati C; Bugatti A; Ronca R; Nicoli S; Moroni E; Stabile H; Camozzi M; Hernandez GA; Mitola S; Dell'Era P; Rusnati M; Ribatti D
Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):71-6. PubMed ID: 15514208
[TBL] [Abstract][Full Text] [Related]
3. Heparan sulfate proteoglycans mediate the angiogenic activity of the vascular endothelial growth factor receptor-2 agonist gremlin.
Chiodelli P; Mitola S; Ravelli C; Oreste P; Rusnati M; Presta M
Arterioscler Thromb Vasc Biol; 2011 Dec; 31(12):e116-27. PubMed ID: 21921258
[TBL] [Abstract][Full Text] [Related]
4. Sulfated K5 Escherichia coli polysaccharide derivatives: A novel class of candidate antiviral microbicides.
Rusnati M; Vicenzi E; Donalisio M; Oreste P; Landolfo S; Lembo D
Pharmacol Ther; 2009 Sep; 123(3):310-22. PubMed ID: 19447134
[TBL] [Abstract][Full Text] [Related]
5. Thrombospondin-1/HIV-1 tat protein interaction: modulation of the biological activity of extracellular Tat.
Rusnati M; Taraboletti G; Urbinati C; Tulipano G; Giuliani R; Molinari-Tosatti MP; Sennino B; Giacca M; Tyagi M; Albini A; Noonan D; Giavazzi R; Presta M
FASEB J; 2000 Oct; 14(13):1917-30. PubMed ID: 11023976
[TBL] [Abstract][Full Text] [Related]
6. Toward a biotechnological heparin through combined chemical and enzymatic modification of the Escherichia coli K5 polysaccharide.
Naggi A; Torri G; Casu B; Oreste P; Zoppetti G; Li JP; Lindahl U
Semin Thromb Hemost; 2001 Oct; 27(5):437-43. PubMed ID: 11668413
[TBL] [Abstract][Full Text] [Related]
7. Broad spectrum inhibition of HIV-1 infection by sulfated K5 Escherichia coli polysaccharide derivatives.
Vicenzi E; Gatti A; Ghezzi S; Oreste P; Zoppetti G; Poli G
AIDS; 2003 Jan; 17(2):177-81. PubMed ID: 12545076
[TBL] [Abstract][Full Text] [Related]
8. Highly sulfated K5 Escherichia coli polysaccharide derivatives inhibit respiratory syncytial virus infectivity in cell lines and human tracheal-bronchial histocultures.
Cagno V; Donalisio M; Civra A; Volante M; Veccelli E; Oreste P; Rusnati M; Lembo D
Antimicrob Agents Chemother; 2014 Aug; 58(8):4782-94. PubMed ID: 24914125
[TBL] [Abstract][Full Text] [Related]
9. Fibroblast growth factor-2 antagonist activity and angiostatic capacity of sulfated Escherichia coli K5 polysaccharide derivatives.
Leali D; Belleri M; Urbinati C; Coltrini D; Oreste P; Zoppetti G; Ribatti D; Rusnati M; Presta M
J Biol Chem; 2001 Oct; 276(41):37900-8. PubMed ID: 11473122
[TBL] [Abstract][Full Text] [Related]
10. Sulfated K5 Escherichia coli polysaccharide derivatives inhibit human immunodeficiency type-1 (HIV-1) infection: candidate microbicides to prevent sexual HIV transmission.
Pacciarini F; Ghezzi S; Pinna D; Cima S; Zoppetti G; Oreste P; Poli G; Vicenzi E
New Microbiol; 2004 Apr; 27(2 Suppl 1):5-9. PubMed ID: 15646059
[TBL] [Abstract][Full Text] [Related]
11. Sulfated K5 Escherichia coli polysaccharide derivatives as wide-range inhibitors of genital types of human papillomavirus.
Lembo D; Donalisio M; Rusnati M; Bugatti A; Cornaglia M; Cappello P; Giovarelli M; Oreste P; Landolfo S
Antimicrob Agents Chemother; 2008 Apr; 52(4):1374-81. PubMed ID: 18250186
[TBL] [Abstract][Full Text] [Related]
12. Interaction of HIV-1 Tat protein with heparin. Role of the backbone structure, sulfation, and size.
Rusnati M; Coltrini D; Oreste P; Zoppetti G; Albini A; Noonan D; d'Adda di Fagagna F; Giacca M; Presta M
J Biol Chem; 1997 Apr; 272(17):11313-20. PubMed ID: 9111037
[TBL] [Abstract][Full Text] [Related]
13. Sulfated polymannuroguluronate, a novel anti-AIDS drug candidate, inhibits HIV-1 Tat-induced angiogenesis in Kaposi's sarcoma cells.
Lu CX; Li J; Sun YX; Qi X; Wang QJ; Xin XL; Geng MY
Biochem Pharmacol; 2007 Nov; 74(9):1330-9. PubMed ID: 17868650
[TBL] [Abstract][Full Text] [Related]
14. BSA conjugates bearing multiple copies of the basic domain of HIV-1 Tat: Prototype for the development of multitarget inhibitors of extracellular Tat.
Bugatti A; Chiodelli P; Rosenbluh J; Loyter A; Rusnati M
Antiviral Res; 2010 Jul; 87(1):30-9. PubMed ID: 20398703
[TBL] [Abstract][Full Text] [Related]
15. alpha(v)beta3-integrin-dependent activation of focal adhesion kinase mediates NF-kappaB activation and motogenic activity by HIV-1 Tat in endothelial cells.
Urbinati C; Bugatti A; Giacca M; Schlaepfer D; Presta M; Rusnati M
J Cell Sci; 2005 Sep; 118(Pt 17):3949-58. PubMed ID: 16105876
[TBL] [Abstract][Full Text] [Related]
16. The perlecan heparan sulfate proteoglycan mediates cellular uptake of HIV-1 Tat through a pathway responsible for biological activity.
Argyris EG; Kulkosky J; Meyer ME; Xu Y; Mukhtar M; Pomerantz RJ; Williams KJ
Virology; 2004 Dec; 330(2):481-6. PubMed ID: 15567441
[TBL] [Abstract][Full Text] [Related]
17. O-sulfated bacterial polysaccharides with low anticoagulant activity inhibit metastasis.
Borgenström M; Wärri A; Hiilesvuo K; Käkönen R; Käkönen S; Nissinen L; Pihlavisto M; Marjamäki A; Vlodavsky I; Naggi A; Torri G; Casu B; Veromaa T; Salmivirta M; Elenius K
Semin Thromb Hemost; 2007 Jul; 33(5):547-56. PubMed ID: 17629853
[TBL] [Abstract][Full Text] [Related]
18. Alpha,alpha-trehalose derivatives bearing guanidino groups as inhibitors to HIV-1 Tat-TAR RNA interaction in human cells.
Wang M; Xu Z; Tu P; Yu X; Xiao S; Yang M
Bioorg Med Chem Lett; 2004 May; 14(10):2585-8. PubMed ID: 15109657
[TBL] [Abstract][Full Text] [Related]
19. Heparin-mimicking sulfonic acid polymers as multitarget inhibitors of human immunodeficiency virus type 1 Tat and gp120 proteins.
Bugatti A; Urbinati C; Ravelli C; De Clercq E; Liekens S; Rusnati M
Antimicrob Agents Chemother; 2007 Jul; 51(7):2337-45. PubMed ID: 17452490
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis, and biological evaluation of novel quinoline derivatives as HIV-1 Tat-TAR interaction inhibitors.
Chen S; Chen R; He M; Pang R; Tan Z; Yang M
Bioorg Med Chem; 2009 Mar; 17(5):1948-56. PubMed ID: 19217787
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
